NYSDOH Guidance for Administration of the Second Dose of COVID-19 Vaccine
There are currently two COVID-19 vaccines authorized for emergency use in the United States: BNT162b2, produced by Pfizer-BioNTech; and mRNA-1273, produced by Moderna. Each of these vaccines have been granted Emergency Use Authorization by the FDA based on a two-dose series. SeeĀ full guidance here for administration of the second dose of these vaccines.
NYSHFA/NYSCAL CONTACTS:
Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15
Tarrah Quinlan, RN, BSN
Director of Education Program Development and Member Operations
518-462-4800 x20
Posted in Clinical & Quality